What Is the QLTY ETF? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
The GMO U.S. Quality ETF (QLTY) is an actively managed fund that selects high-quality large-cap U.S. stocks. It focuses on companies with strong profitability and financial health, and its management strategy, distributions and fee gap versus similar quality factor ETFs are the key criteria for an investment decision.
What Is the GMO U.S. Quality ETF?
This is an active ETF in which the management team selects U.S.-listed companies with high returns on capital, low debt burdens and stable earnings. Rather than mechanically replicating a specific index, it builds its portfolio around large-cap stocks that pass its quality screening criteria.
It suits long-term investors who want exposure to U.S. large caps while putting earnings quality and financial stability first.
It is an ETF run with an active management approach by GMO.
How Does the GMO U.S. Quality ETF Invest?
| Item | Details |
|---|---|
| Tracking Index | No separate benchmark index (actively managed) |
| Management Style | Active (selected by the management team) |
| Rebalancing Frequency | As needed, at the management team's discretion |
| Distribution Frequency | Quarterly |
| Expense Ratio | 0.50% |
| Asset Manager | GMO |
The fund screens U.S. large caps on return on capital, earnings stability and balance sheet structure, then sets weights while also weighing valuation. Because the inclusion criterion is the quality of the business rather than index membership, its sector and stock mix differs from that of market-cap-weighted indexes.
- Selection by the management team rather than index replication
- Transparent structure with holdings disclosed daily
- A long-running quality strategy delivered in ETF form
GMO U.S. Quality ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $5.6B, and the expense ratio is 0.50% per year.
Because of its active management structure, the fee burden is heavier than that of passive quality factor ETFs. In exchange, it has room to adjust holdings without being bound by index rules.
GMO U.S. Quality ETF Performance and Trends
Given its quality-stock selection strategy, the fund carries a large weighting in companies with highly stable earnings, so its declines tend to be relatively limited when markets swing sharply. Conversely, it can lag during rebounds led by lower-quality stocks.
Capital tends to flow into the quality factor when the outlook for interest rates and the economy is uncertain. When risk appetite strengthens, however, money moves toward growth and momentum strategies, and there are periods when relative performance is held back.
GMO U.S. Quality ETF Pros and Cons
Its strength is active management that picks stocks based on earnings quality, while the higher fee compared with passive funds and its reliance on management judgment are drawbacks.
💪 Key Strengths
⚠️ Points to Watch
GMO U.S. Quality ETF Alternative ETFs and Related Products
GARP (ETF) and VFQY (ETF), shown in the table, belong to the same U.S. quality factor group and are lower-fee alternatives because they are run on a rules basis, while QLC (ETF) is also close in character as a large-cap quality approach. For exposure that also covers small-cap dividends, the OUSM family is a comparison candidate, and for an approach that layers momentum on top of quality, the JOET family is. Beyond the table, broad core funds such as VOO and VTI, flagship quality products such as QUAL and SPHQ, and the dividend growth fund SCHD are also worth reviewing alongside it.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| iShares MSCI USA Quality GARP ETF | $76.13 | -0.7% | $3.5B | 0.15% | 0.27% | +11.4% | |
| Northern Trust US Quality Large Cap ETF | $88.49 | -0.3% | $1.1B | 0.25% | 0.98% | +10.5% | |
| ALPS OShares U.S. Small-Cap Quality Dividend ETF | $49.71 | +0.1% | $826.5M | 0.48% | 1.94% | +13.5% | |
| Vanguard U.S. Quality Factor ETF | $176.91 | -0.2% | $521.6M | 0.13% | 1% | +17.8% | |
| Virtus Terranova U.S. Quality Momentum ETF | $44.61 | +0.2% | $227.1M | 0.29% | 0.62% | +4.3% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| MSFT | Microsoft Corp | 0.20% | $533.42 | -2.2% | $3.96T | 27.9 | 0.73% |
| GOOG | Alphabet Inc | 0.10% | $284.92 | -0.4% | $3.50T | 14.9 | 0.31% |
| LRCX | Lam Research Corp | 0.11% | $222.39 | +0.5% | $277.8B | 33.1 | 0.59% |
| GOOGL | Alphabet Inc | 0.05% | $287.38 | -0.3% | $3.50T | 15.0 | 0.3% |
| AAPL | Apple Inc | 0.05% | $348.56 | -0.6% | $5.07T | 38.8 | 0.33% |
| JNJ | Johnson & Johnson | 0.05% | $280.78 | -0.5% | $675.9B | 42.6 | 1.9% |
GMO U.S. Quality ETF Investor Checkpoints
Here are the items to check before buying this ETF. Because it is an actively managed product, you should first understand its fee level and stock selection criteria, and also check whether it overlaps with the U.S. large-cap assets you already hold.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check the effect of cumulative costs over a long holding period | Higher than passive funds |
| 🧭 Management Style | Understand that it is selective management, not index tracking | Active management |
| 🔁 Holdings Overlap | Check whether it overlaps with U.S. large-cap funds you already hold | Needs checking |
| 💱 Exchange Rate | Effect on returns converted into Korean won | No currency hedge applied |
Because the management team's selection drives results, performance can diverge from low-fee passive funds if its judgment misses. With a large weighting in large caps, it will also pull back when the broader market falls.
It is an option worth considering if you want to hold U.S. large caps chosen on earnings quality. If cost is your priority, compare rules-based quality products; if you want room for selective management, compare this ETF.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of September 3, 2026.